Home > > Middle East & Africa And Global ePharmacy Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: MIDDLE EAST & AFRICA EPHARMACY MARKET 3.1. OVERVIEW 3.2. MIDDLE EAST & AFRICA 3.2.1. MIDDLE EAST & AFRICA EPHARMACY MARKET, BY THERAPY AREA 3.2.2. MIDDLE EAST & AFRICA EPHARMACY MARKET, BY PRODUCT 3.2.3. MIDDLE EAST & AFRICA EPHARMACY MARKET, BY COUNTRY 3.2.3.1. BRAZIL 3.2.3.1.1. BRAZIL EPHARMACY MARKET, BY THERAPY AREA 3.2.3.1.2. BRAZIL EPHARMACY MARKET, BY PRODUCT 3.2.3.2. SOUTH AFRICA 3.2.3.2.1. SOUTH AFRICA EPHARMACY MARKET, BY THERAPY AREA 3.2.3.2.2. SOUTH AFRICA EPHARMACY MARKET, BY PRODUCT 3.2.3.3. GCC 3.2.3.3.1. GCC EPHARMACY MARKET, BY THERAPY AREA 3.2.3.3.2. GCC EPHARMACY MARKET, BY PRODUCT 3.2.3.4. REST OF MENA 3.2.3.4.1. REST OF MENA EPHARMACY MARKET, BY THERAPY AREA 3.2.3.4.2. REST OF MENA EPHARMACY MARKET, BY PRODUCT CHAPTER 4: GLOBAL EPHARMACY MARKET, BY THERAPY AREA 4.1. OVERVIEW 4.2. WEIGHT LOSS 4.2.1. WEIGHT LOSS MARKET, BY REGION 4.2.1.1. NORTH AMERICA WEIGHT LOSS MARKET, BY COUNTRY 4.2.1.2. EUROPE WEIGHT LOSS MARKET, BY COUNTRY 4.2.1.3. ASIA WEIGHT LOSS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA WEIGHT LOSS MARKET, BY COUNTRY 4.3. VITAMINS 4.3.1. VITAMINS MARKET, BY REGION 4.3.1.1. NORTH AMERICA VITAMINS MARKET, BY COUNTRY 4.3.1.2. EUROPE VITAMINS MARKET, BY COUNTRY 4.3.1.3. ASIA VITAMINS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA VITAMINS MARKET, BY COUNTRY 4.4. COLD & FLU 4.4.1. COLD & FLU MARKET, BY REGION 4.4.1.1. NORTH AMERICA COLD & FLU MARKET, BY COUNTRY 4.4.1.2. EUROPE COLD & FLU MARKET, BY COUNTRY 4.4.1.3. ASIA COLD & FLU MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA COLD & FLU MARKET, BY COUNTRY 4.5. DERMATOLOGY 4.5.1. DERMATOLOGY MARKET, BY REGION 4.5.1.1. NORTH AMERICA DERMATOLOGY MARKET, BY COUNTRY 4.5.1.2. EUROPE DERMATOLOGY MARKET, BY COUNTRY 4.5.1.3. ASIA DERMATOLOGY MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA DERMATOLOGY MARKET, BY COUNTRY 4.6. OTHER THERAPY AREAS 4.6.1. OTHER THERAPY AREAS MARKET, BY REGION 4.6.1.1. NORTH AMERICA OTHER THERAPY AREAS MARKET, BY COUNTRY 4.6.1.2. EUROPE OTHER THERAPY AREAS MARKET, BY COUNTRY 4.6.1.3. ASIA OTHER THERAPY AREAS MARKET, BY COUNTRY 4.6.1.4. MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET, BY COUNTRY CHAPTER 5: GLOBAL EPHARMACY MARKET, BY PRODUCT 5.1. OVERVIEW 5.2. OTC MEDICINE 5.2.1. OTC MEDICINE MARKET, BY REGION 5.2.1.1. NORTH AMERICA OTC MEDICINE MARKET, BY COUNTRY 5.2.1.2. EUROPE OTC MEDICINE MARKET, BY COUNTRY 5.2.1.3. ASIA OTC MEDICINE MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA OTC MEDICINE MARKET, BY COUNTRY 5.3. PRESCRIPTION MEDICINE 5.3.1. PRESCRIPTION MEDICINE MARKET, BY REGION 5.3.1.1. NORTH AMERICA PRESCRIPTION MEDICINE MARKET, BY COUNTRY 5.3.1.2. EUROPE PRESCRIPTION MEDICINE MARKET, BY COUNTRY 5.3.1.3. ASIA PRESCRIPTION MEDICINE MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET, BY COUNTRY FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 02. GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 03. GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 04. GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($MILLION) TABLE 06. MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) TABLE 07. MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. BRAZIL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 09. BRAZIL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 10. SOUTH AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 11. SOUTH AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 12. GCC EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 13. GCC EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 14. REST OF MENA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 15. REST OF MENA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 16. GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) TABLE 17. WEIGHT LOSS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 18. NORTH AMERICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. EUROPE WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. ASIA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 21. MIDDLE EAST & AFRICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. VITAMINS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 23. NORTH AMERICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. EUROPE VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. ASIA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 26. MIDDLE EAST & AFRICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. COLD & FLU MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 28. NORTH AMERICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. EUROPE COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. ASIA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. MIDDLE EAST & AFRICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. DERMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 33. NORTH AMERICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. EUROPE DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. ASIA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. MIDDLE EAST & AFRICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. OTHER THERAPY AREAS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 38. NORTH AMERICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. EUROPE OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. ASIA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) TABLE 43. OTC MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 44. NORTH AMERICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. EUROPE OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. ASIA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. MIDDLE EAST & AFRICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. PRESCRIPTION MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 49. NORTH AMERICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. EUROPE PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. ASIA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: BRAZIL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BRAZIL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 11. TOP INVESTMENT POCKETS: BRAZIL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BRAZIL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: SOUTH AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SOUTH AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: SOUTH AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SOUTH AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: GCC EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GCC EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: GCC EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GCC EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: REST OF MENA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: REST OF MENA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: REST OF MENA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: REST OF MENA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: WEIGHT LOSS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: WEIGHT LOSS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 29. TOP INVESTMENT POCKETS: NORTH AMERICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: EUROPE WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: ASIA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 37. TOP INVESTMENT POCKETS: VITAMINS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: VITAMINS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 39. TOP INVESTMENT POCKETS: NORTH AMERICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: EUROPE VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: ASIA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 47. TOP INVESTMENT POCKETS: COLD & FLU MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: COLD & FLU MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 49. TOP INVESTMENT POCKETS: NORTH AMERICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 51. TOP INVESTMENT POCKETS: EUROPE COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 52. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 53. TOP INVESTMENT POCKETS: ASIA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 54. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 55. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 56. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 57. TOP INVESTMENT POCKETS: DERMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 58. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: DERMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 59. TOP INVESTMENT POCKETS: NORTH AMERICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 60. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 61. TOP INVESTMENT POCKETS: EUROPE DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 62. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 63. TOP INVESTMENT POCKETS: ASIA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 64. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 65. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 66. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 67. TOP INVESTMENT POCKETS: OTHER THERAPY AREAS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 68. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTHER THERAPY AREAS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 69. TOP INVESTMENT POCKETS: NORTH AMERICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 70. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 71. TOP INVESTMENT POCKETS: EUROPE OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 72. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 73. TOP INVESTMENT POCKETS: ASIA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 74. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 75. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 76. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 77. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 78. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 79. TOP INVESTMENT POCKETS: OTC MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 80. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTC MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 81. TOP INVESTMENT POCKETS: NORTH AMERICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 82. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 83. TOP INVESTMENT POCKETS: EUROPE OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 84. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 85. TOP INVESTMENT POCKETS: ASIA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 86. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 87. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 88. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 89. TOP INVESTMENT POCKETS: PRESCRIPTION MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 90. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: PRESCRIPTION MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 91. TOP INVESTMENT POCKETS: NORTH AMERICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 92. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 93. TOP INVESTMENT POCKETS: EUROPE PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 94. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 95. TOP INVESTMENT POCKETS: ASIA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 96. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 97. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES FIGURE 01. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 02. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY REGION, 2023-2030, ($MILLION) FIGURE 03. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($MILLION) FIGURE 04. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($MILLION) FIGURE 05. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) FIGURE 06. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($MILLION) FIGURE 07. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 08. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA EPHARMACY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 09. TOP INVESTMENT POCKETS: BRAZIL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 10. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BRAZIL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 11. TOP INVESTMENT POCKETS: BRAZIL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 12. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: BRAZIL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 13. TOP INVESTMENT POCKETS: SOUTH AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 14. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SOUTH AFRICA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 15. TOP INVESTMENT POCKETS: SOUTH AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 16. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: SOUTH AFRICA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 17. TOP INVESTMENT POCKETS: GCC EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 18. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GCC EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 19. TOP INVESTMENT POCKETS: GCC EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 20. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GCC EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 21. TOP INVESTMENT POCKETS: REST OF MENA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 22. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: REST OF MENA EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 23. TOP INVESTMENT POCKETS: REST OF MENA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 24. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: REST OF MENA EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 25. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 26. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY THERAPY AREA, 2023-2030, ($ MILLION) FIGURE 27. TOP INVESTMENT POCKETS: WEIGHT LOSS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 28. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: WEIGHT LOSS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 29. TOP INVESTMENT POCKETS: NORTH AMERICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 30. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 31. TOP INVESTMENT POCKETS: EUROPE WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 32. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 33. TOP INVESTMENT POCKETS: ASIA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 34. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 35. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 36. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA WEIGHT LOSS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 37. TOP INVESTMENT POCKETS: VITAMINS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 38. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: VITAMINS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 39. TOP INVESTMENT POCKETS: NORTH AMERICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 40. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 41. TOP INVESTMENT POCKETS: EUROPE VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 42. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 43. TOP INVESTMENT POCKETS: ASIA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 44. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 45. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 46. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA VITAMINS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 47. TOP INVESTMENT POCKETS: COLD & FLU MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 48. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: COLD & FLU MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 49. TOP INVESTMENT POCKETS: NORTH AMERICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 50. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 51. TOP INVESTMENT POCKETS: EUROPE COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 52. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 53. TOP INVESTMENT POCKETS: ASIA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 54. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 55. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 56. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA COLD & FLU MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 57. TOP INVESTMENT POCKETS: DERMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 58. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: DERMATOLOGY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 59. TOP INVESTMENT POCKETS: NORTH AMERICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 60. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 61. TOP INVESTMENT POCKETS: EUROPE DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 62. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 63. TOP INVESTMENT POCKETS: ASIA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 64. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 65. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 66. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA DERMATOLOGY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 67. TOP INVESTMENT POCKETS: OTHER THERAPY AREAS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 68. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTHER THERAPY AREAS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 69. TOP INVESTMENT POCKETS: NORTH AMERICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 70. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 71. TOP INVESTMENT POCKETS: EUROPE OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 72. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 73. TOP INVESTMENT POCKETS: ASIA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 74. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 75. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 76. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTHER THERAPY AREAS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 77. TOP INVESTMENT POCKETS: GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 78. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: GLOBAL EPHARMACY MARKET VALUE, BY PRODUCT, 2023-2030, ($ MILLION) FIGURE 79. TOP INVESTMENT POCKETS: OTC MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 80. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: OTC MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 81. TOP INVESTMENT POCKETS: NORTH AMERICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 82. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 83. TOP INVESTMENT POCKETS: EUROPE OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 84. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 85. TOP INVESTMENT POCKETS: ASIA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 86. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 87. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 88. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA OTC MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 89. TOP INVESTMENT POCKETS: PRESCRIPTION MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 90. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: PRESCRIPTION MEDICINE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) FIGURE 91. TOP INVESTMENT POCKETS: NORTH AMERICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 92. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: NORTH AMERICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 93. TOP INVESTMENT POCKETS: EUROPE PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 94. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: EUROPE PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 95. TOP INVESTMENT POCKETS: ASIA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 96. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: ASIA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 97. TOP INVESTMENT POCKETS: MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) FIGURE 98. INCREMENTAL OPPORTUNITY ANALYSIS PLOTTING: MIDDLE EAST & AFRICA PRESCRIPTION MEDICINE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)